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A MODEL FOR LIFE
Communicating the molecular basis of cancer cell-by-cell: an
interview with Tatsushi Igaki
Tatsushi Igaki is currently based at the Kyoto University Graduate
School of Biostudies, where he leads a research group dedicated
to using Drosophila genetics to build a picture of the cell-cell
communications underlying the establishment and maintenance
of multicellular systems. His work has provided insight into the
molecular bases of cell competition in the context of development
and tumorigenesis, including the landmark discovery that
oncogenic cells communicate with normal cells in the tumor
microenvironment to induce tumor progression in a non-
autonomous fashion. In this interview, he describes his career
path, highlighting the shift in his research focus from the basic
principles of apoptosis to clonal evolution in cancer, and also
explains why Drosophila provides a powerful model system for
studying cancer biology.
KEY WORDS: Drosophila, Apoptosis, Cancer
Tatsushi Igaki was born in Okayama, Japan, in 1970. He
obtained a Bachelor’s degree in Pharmaceutical Sciences from
Okayama University, where he carried out research on
apoptosis using cultured cells under the supervision of
Hikoya Hayatsu and Yusuke Wataya. After graduation, he
started working on neuronal apoptosis at the Research Institute
of Kyorin Pharmaceutical Company but, after working at
the company for 4 years, he went back to academia and
enrolled as a graduate student at the Graduate School of
Medicine at Osaka University. Tatsushi’s first introduction to
Drosophila as a model came during this time, and he used
flies to further explore the molecular underpinnings of
apoptosis under the supervision of Masayuki Miura. He then
moved on to Yale University to work in Tian Xu’s lab, where
he harnessed the genetic tools and resources provided by the
group to shed light on cell-cell communications and signaling
pathways relevant to tumor metastasis. In 2007, he got an
independent Assistant Professor position in the Graduate
School of Medicine at Kobe University in Japan. He secured
tenure a few years later and moved to the Graduate School of
Biostudies at Kyoto University as a full Professor. Nowadays,
his group uses Drosophila as a platform to study cell-cell
communication in epithelial tissues, focusing on cell
‘competition’ and ‘cooperation’, with the aim of
understanding how multicellular systems are maintained and
how dysregulation of these processes leads to cancer.
Why did you decide to pursue a career in science?
I first became interested in science in high school, and my
interest intensified when I started my first research project as
an undergraduate student in Hikoya Hayatsu’s lab. In the
course of this project I first mastered how to quantify the
intracellular dNTP [deoxyribonucleotide triphosphate; dATP,
dTTP, dGTP and dCTP] pool using HPLC [high performance
liquid chromatography], and my first ‘real’ experiment was to
analyze the dNTP pool obtained from mutagen-treated mouse
cells, which had been prepared by a senior lab member. The
aim of this work was to determine whether the balance in the
intracellular dNTP pool was disrupted by mutagen treatment,
and my experiment showed that there was no significant
effect. However, I realized that there was an additional small
peak in my HPLC chromatogram that did not correspond to
any dNTP standards. I thought that, because the mutagen used
was a nucleoside analog, it has somehow been metabolized
within the cell and was utilized for the dNTP pool. I
hypothesized that this could be the cause for decreased
viability in mutagen-treated cells. Although my colleague did
not care about the small peak, I couldn’t help thinking about
it because I realized that, in the whole world, only I knew
about it – this really motivated me to investigate it. Yusuke
Wataya, an Associate Professor who directly supervised me,
was generous enough to allow me to pursue the finding during
my undergraduate work. I really enjoyed the project, and
finally found that the small peak was indeed derived from a
chemically modified dNTP generated in mutagen-treated cells.
It was just a tiny piece of work, like a small peak in my life,
but I really learned what science is from the experience – the
opportunity to make new and exciting discoveries by
following the heart. I decided then and there to spend my
life doing research.
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“It was just a tiny piece of work, like a
small peak in my life, but I really learned
what science is from the experience – the
opportunity to make new and exciting
discoveries by following the heart”
For your PhD, you investigated mechanisms of apoptosis in
Drosophila. Were you particularly interested in this topic and
in working on Drosophila or did you stumble upon the field?
During my time in industry, I read many papers in the apoptosis
field. That period, 1995-1999, was the golden age of apoptosis
research. I was attracted by the mechanism of apoptosis, which
seemed beautiful in its simplicity. Although I didn’t have many
opportunities to attend meetings or even discuss advances in the
field with other researchers, I followed the field by reading
papers. I still clearly remember when I finally decided to go back
to academia. It was when I stood reading a new issue of Cell
[August 21, 1998] in the library during a lunch break. In that
issue, I found two back-to-back papers from Junying Yuan’s lab
and Xiaodong Wang’s lab that beautifully demonstrated, using
mouse genetics, the molecular basis of why a death-ligand, Fas,
causes apoptosis through different pathways in different cell
types. They were elegant studies that clearly resolved an
important issue, and I was shocked that it had taken a year for
the knowledge to get to me, because I wasn’t a researcher in the
field. I felt that I needed to go back to academia as soon as
possible, so I applied for a PhD position in Masayuki Miura’s
group at Osaka University. During the interview for this position,
Masayuki told me that he had just started working on Drosophila
to understand apoptosis at the organismal level and was going to
shift his focus from cultured cells to flies. I had been impressed
by fly genetics and I instantly agreed to his direction. Indeed,
working with flies has changed my view of science. In contrast to
the cultured cells that I had been working with before, first and
foremost flies give us insight into the phenomenon of life. We are
instantly convinced of the importance of a particular biological
process before we start dissecting its molecular mechanism. “Ask
living organisms if you want to know the mechanism.” This is
one of the most valuable pieces of advice I received from
Masayuki Miura, who has always been my idol.
Can you tell us more about your PhD work? What was your
greatest achievement?
In the course of my PhD, I characterized the first Drosophila
homolog of Bcl-2 as a prototype of pro-apoptotic Bcl-2 family
members, and identified the first and sole ortholog of tumor necrosis
factor [TNF]. I named this TNF ortholog ‘Eiger’, after the
impressive mountain that I had visited 4 years earlier with my
wife. Thirteen years after the discovery, Eiger is now recognized as
one of the key molecules that regulate tissue homeostasis and tumor
development in flies. The identification of a TNF ortholog implied
the existence of mammalian-like ‘context-dependent’ or ‘stochastic’
cell-death regulation, in addition to genetically programmed cell-
death mechanisms. Eiger thus gave me the opportunity to dissect
complex cell-death regulation through cell-cell communications. I
was really interested in this possibility and it made me further
recognize the advantages of working in flies – this question couldn’t
be studied in other invertebrate model organisms such asC. elegans,
where all cell fates are genetically programmed.
After your PhD, you moved to Yale University to work in Tian
Xu’s lab. What stimulated this choice?
Tian Xu’s group had established the FLP/FRT-mediated
genetic mosaic technique that enables us to study cell-cell
communications in fly tissues by ‘clonal analysis’. I decided to
join Tian’s lab because, as a continuation of my PhD work, I
wanted to use the genetic mosaic technique to study stochastic
cell-death regulation through cell-cell communications. Tian’s lab
had a lot of useful tools and valuable expertise, and I expected that,
using their genetic mosaic technique, I would be able to get close
to a concept that explains how cell-cell communications underlie
the establishment of a complex multicellular system. In addition to
this, when I was interviewed by Tian on the phone, he told me
about his recently established fly model of tumor metastasis,
which they were about to submit to Science. This was the first
Drosophila genetic model of tumor metastasis, in which GFP-
labeled tumor cells induced in the larval eye tissues overgrow,
degrade basement membrane, migrate out of the eye tissue, and
invade into neighboring tissue called ventral nerve cord or
metastasize to distant organs. Gene expression can be easily
manipulated within tumor cells, and the model can be used to
screen for genes involved in metastasis. This unique and
interesting model, which is now widely used by Drosophila labs
interested in cancer, further stimulated me to move to Tian’s lab.
WasyourexperienceatYale important forconsolidating your
research interests as a PI?
Definitely. Without my experience in Tian’s lab, I would be
moving in a different direction now. I spent four and a half years
at Yale, and it was definitely one of the most wonderful times for
me in both science and life. Tian is a great scientist, with
extremely unique ideas and a very logical way of thinking. When
I was struggling with my manuscripts, I often drove to Tian’s
house to have discussions that frequently went on until after
midnight. I am sure that all my interactions with him significantly
influenced my sense and style of science.
In Tian’s lab, I first worked on the signaling mechanisms
involved in tumor metastasis, using clonal analysis. During this
time, I came across an interesting phenomenon: clones of
oncogenic cells deficient for a neoplastic tumor-suppressor gene,
scribble, are actively eliminated from the epithelial tissue when
surrounded by wild-type cells; a process that has now been
recognized as a type of ‘cell competition’. This phenomenon was
first reported by Helena Richardson’s group, but we could finally
unveil the underlying mechanism, in which Eiger plays a central
role. We found that Eiger is activated in oncogenic scribble
mutant cells when surrounded by wild-type cells and leads to
activation of downstream JNK signaling, which causes
elimination of scribble mutant cells. It was amazing for me,
because the Eiger-deficient flies that I generated as a graduate
student gave no phenotype, so I disappointedly thought that
Eiger might not be important. I could finally elucidate the
physiological role of Eiger, which is latent in the normal
situation but is activated when a tissue needs to eliminate
dangerous cells such as oncogenic mutant cells: a fail-safe
mechanism of the epithelial tissue against neoplastic
development. At this point I had a clear vision of what I
wanted to work on and knew I was ready to become independent.
Since that time I have devoted my research to studying the basic
principles of epithelial cell-cell communications in tissue
homeostasis, tissue growth and tumorigenesis through clonal
analyses.
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Was it, in a way, a natural evolution for you to move from
apoptosis to the study of cancer?
I have been interested in cancer since the early days of my career. As
an undergraduate student I was really attracted to molecular biology
and felt that cancer would be one of the most interesting questions to
be addressing using molecular biology tools. Apoptosis, which is a
longstanding interest ofmine, is acentral aspect of cancer.But I donot
think that I havemade an activemove frombasic tomore translational
research. In my mind, I have consistently focused on the rather
fundamental basic principles of biological phenomena, which are
indeed often related to cancer. Of course, an ultimate goal is that the
concepts emerging from our fly work contribute to development of a
revolutionary anti-cancer strategy, but I have consistently approached
the question from a basic standpoint. I am now interested in epithelial
cell-cell communications, especially cell-cell cooperation and
competition, which I believe would lead to the understanding of
multicellularity, tissue homeostasis and, ultimately, cancer.
Your group has contributed to dissecting how certain
alterations in oncogenic cells can induce growth and
metastatic behavior in the surrounding tissue. Could you tell
usmore about these findings and the implications for cancer
therapy?
Wehave found through a genetic screen inDrosophila epithelium that
clones of cells with oncogenic Ras activation and mitochondrial
dysfunction cause their surrounding benign tumors to acquire
metastatic abilities – this is termed ‘non-autonomous’ tumor
progression. Both Ras activation and mitochondrial dysfunction are
frequentlyobserved in human cancers, andwe found that, remarkably,
these twomutations collaborate to induce drastic tumor progression in
neighboring tissue. Importantly, mutant cells with simultaneous Ras
activation andmitochondrial dysfunction donot overgrow, but instead
they undergo cellular senescence. Thus, such mutant cells behave as
‘oncogenic niche cells’ to constantly promote non-autonomous tumor
progression. An implication of our findings from a translational
viewpoint is that it reminds researchers to look at cancer as a
heterogeneous mutant cell population in which there are constant
oncogenic cell-cell communications. Researchers may further find
that someotheroncogenes or tumor-suppressor genes thatwe thinkwe
understand well also have unexpected, non-autonomous oncogenic
activities in vivo. This seems to make cancer more complicated but, at
the same time, raises hope for cancer therapy because, by delving
deeper into cancer biology, we uncover more therapeutic targets.
Although we are still far from using this knowledge for cancer
treatment, I believe that it will contribute to the development of new
cancer therapies in the future. I think the biggest role ofDrosophila in
cancer research is to provide a conceptual advance in understanding
the basic biology, which, in turn, informs the drug discovery process.
“An implication of our findings from a
translational viewpoint is that it reminds
researchers to look at cancer as a
heterogeneous mutant cell population
in which there are constant oncogenic
cell-cell communications”
What makes Drosophila a good model for understanding
cancer biology?
The biggest advantage to using Drosophila for studying
tumorigenesis, at least for me, is the ability to apply clonal analysis
in the model. Tumors arise from a single or a few mutant cells
emerging from a normal epithelial sheet. Such mutant cells undergo
clonal expansion and evolution into cancer cells via cell-cell
communication between mutant cells and surrounding normal cells.
Drosophila is the only genetically tractable model animal that we can
use to systematically study such oncogenic cell-cell communication at
the organismal level. This is enabling us to gradually dissect the basic
principle of clonal evolution in the context of cancer. It is also a crucial
benefit for my work that, in Drosophila, we can perform unbiased
genetic screens that provide us with clues for solving the many
complex mysteries of biological systems, which are otherwise often
impenetrable.Of course,Drosophila has some obvious limitations for
studying tumor growth and metastasis, as it lacks a vascular system,
the adaptive immune system, typical epithelial-mesenchymal cell
interactions and postnatal cancer. But I think these are small issues
and can be overcome. Flies have many other advantages, and I am
overall very pleased toworkwith this beautiful animalwith twowings
and six legs.
What recommendations would you give to PhD students and
young researchers striving to successfully pursue acareer in
science?
I don’t considermyself to be in the position to be able to give advice to
young scientists, but one thing I would say is that it was crucial for me
to work out my lifetime interest as a PhD student and postdoc. Any
kind of science is interesting, but what we can do in the course of our
careers is very limited. I hoped to eventuallybecomeaPI andbeable to
bet my life on my own science, so, I knew that the question I chose
should be unique, enigmatic and, most importantly, fun to tackle.
Trying to pin down my lifetime interest made me think more about
science in general. I think it is important to beconfident inyourchoices
of research interest, whatever other people think. In my case, I knew
that I wanted to dedicate my career to cell-cell communication. I felt
that there was a huge gap between what we know about the molecular
biology of the cell and what we know about how the multicellular
system works. It was so intriguing for me to think about how cells
communicate, cooperate and compete with each other to develop a
complex multicellular system, and to think about pathologies such as
cancer as a failure of normal cell-cell communication. I also tell my
students in the lab that scientists are just like athletes. Our scientific
knowledge, sense, originality and creativity actually come from
everyday hard work, so it is very important for us to keep up our daily
training – just like athletes. These efforts are rewarded in science,
making this career path a worthwhile investment of life.
“Our scientific knowledge, sense,
originality and creativity actually come
from everyday hard work, so it is very
important for us to keep up our daily
training – just like athletes”
What would you like to achieve in the next decade?
I would like to fully understand the basic principles of how cells
develop and maintain a multicellular network. Towards this goal,
my lab is continuing its efforts to understand the molecular basis of
cell-cell cooperation and competition in the epithelial tissue. We are
currently performing more than 15 genetic screens in Drosophila,
which I believe will provide us with some answers in the next
decade, and these could also contribute to the development of new
therapeutic strategies against cancer.
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Moving on from your research, what do you enjoy doing
outside the lab?
I love watching movies and doing sports, especially baseball and
running marathons, as well as climbing mountains with my wife.
DMM greatly appreciates Tatsushi’s willingness to share his unique thoughts and
experiences. Tatsushi was interviewed by Paraminder Dhillon, and the final piece
has been edited and condensed with his approval. With thanks to Alessandra Cifra
for suggestions for interview questions.
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